_susana-m-campos-md-mph-on-the-role-of-parp-inhibitors-in-the-treatment-landscape-of-ovarian-cancer.jpg "Susana M. Campos, MD, MPH, on the Role of PARP Inhibitors in the Treatment Landscape of Ovarian Cancer from parp Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1 min 37 sec
✓ Published: 26-Apr-2018
✓ Published: 26-Apr-2018
Description:
Susana M. Campos, MD, MPH, of Dana-Farber Cancer Institute, discusses recent changes to the NCCN Ovarian Cancer Guidelines and the implications for treatment going forward.
Susana M. Campos, MD, MPH, of Dana-Farber Cancer Institute, discusses recent changes to the NCCN Ovarian Cancer Guidelines and the implications for treatment going forward.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_gynecologic-cancer-education-parp-inhibitor-therapy.webp "Mayo Clinic")
_mechanism-of-action-of-parp-inhibitors-and-targeting-dna-damage-response-ddr.webp "Understand the mechanism of action of PARP inhibitors and targeting DNA Damage Response (DDR) in this short video")
⏲ 3 min 10 sec ✓ 25-Jul-2019
_personalizing-advanced-ovarian-cancer-treatment-with-parp-inhibitors-and-novel-approaches.webp "PeerView Oncology")
⏲ 57 minutes 11 seconds 👁 2.5K
_bono-parp-qu-tan-caro-est2024-gus-lucioni.webp "Gustavo Lucioni")
_parp-inhibitors-for-the-treatment-of-ovarian-cancer-gottfried-konecny-md-124-uclamdchat.webp "UCLA Health")
⏲ 34 minutes 17 seconds 👁 4.6K
_parp-inhibitors-revolutionising-cancer-treatment.webp "astrazeneca")
_linda-mileshkin-mbbs-on-solid-tumors-early-treatment-study-results.webp "Linda Mileshkin, MBBS, of the Peter MacCallum Cancer Centre, discusses phase Ib trial findings on the anti–PD-1 monoclonal antibody BGB-A317 in combination with the PARP inhibitor BGB-290 in advanced solid tumors.")
_an-overview-of-parp-inhibitors-in-ovarian-cancer.webp "Targeted Oncology")
_gynecologic-cancer-education-parp-inhibitor-therapy.jpg)
_mechanism-of-action-of-parp-inhibitors-and-targeting-dna-damage-response-ddr.jpg)
_personalizing-advanced-ovarian-cancer-treatment-with-parp-inhibitors-and-novel-approaches.jpg)
_bono-parp-qu-tan-caro-est2024-gus-lucioni.jpg)
_parp-inhibitors-for-the-treatment-of-ovarian-cancer-gottfried-konecny-md-124-uclamdchat.jpg)
_parp-inhibitors-revolutionising-cancer-treatment.jpg)
_linda-mileshkin-mbbs-on-solid-tumors-early-treatment-study-results.jpg)
_an-overview-of-parp-inhibitors-in-ovarian-cancer.jpg)
![[+]](/images/menu.gif){kind=small}